The use of non-viral nanoparticulate systems for the delivery of therapeutic agents is
receiving considerable attention for medical and pharmaceutical applications. This …

The chemotherapy of infections caused by bacteria that inhabit intracellularly presents a
number of uncommon challenges. Many bacteria have found the way to produce a “silent” …

Infectious diseases are the leading cause of mortality worldwide, with viruses in particular
making global impact on healthcare and socioeconomic development. In addition, the rapid …

The continuous development of drug delivery systems (DDSs) has been extensively
researched by the need to maximize therapeutic efficacy while minimizing undesirable side …

Limitations in therapy induced by adverse effects due to unselective drug availability and
therefore the use of potentially too high doses are a common problem. One prominent …

Development of new delivery systems that deliver the potential drug specifically to the target
site in order to meet the therapeutic needs of the patients at the required time and level …

This article reviews nanoparticulate–chemotherapeutic systems that have been developed
for human therapy, considering the components of the nanoparticles, the therapeutic agents …

Nanoparticle technology has been in the forefront of nanomedicine and innovative
healthcare devices. Although the concept is not new, the advances in biomaterials and the …

Nanomedicine opens new therapeutic avenues for attacking viral diseases and for
improving treatment success rates. Nanoparticulate-based systems might change the …

The advancement in medical sciences and perturbing limitations of some conventional drug
delivery systems have triggered extensive research in nanomedicine, and there have been …